Shareholding disclosure

BIOPHAMAinvest AG

Declared position

2.67%

Threshold

Crossed upwards

Timeline

Published

30.09.2014

Transaction

—

Voting rights breakdown

Voting rights acquired2.67%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAE9T00041

Beneficial owner

BIOPHAMAinvest AG

Declared address

BIOPHAMAinvest AG, 9490 Vaduz

Dilution of ownership percentage as a result of the capital increase from September 2014.

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

BIOPHAMAinvest AG

MindMaze Therapeutics Holding SA30.09.2014TAE9T00041

Disclosure summary

BIOPHAMAinvest AG disclosed a holding in MindMaze Therapeutics Holding SA on the acquisition side, published by SIX Exchange Regulation on 30.09.2014, at 2.67% of voting rights. Notice category: Single shareholder.

Disclosed position

2.67%

Voting rights acquired

Voting rights acquired2.67%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

BIOPHAMAinvest AG disclosed a holding in MindMaze Therapeutics Holding SA, published on 30.09.2014.

Publication date30.09.2014

Issuing companyMindMaze Therapeutics Holding SA

Beneficial ownerBIOPHAMAinvest AG

Declared addressBIOPHAMAinvest AG, 9490 Vaduz

CategorySingle shareholder

Voting rights acquired2.67%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAE9T00041

Conditions

Dilution of ownership percentage as a result of the capital increase from September 2014.

Source: SIX Exchange Regulation · Publication date: 30.09.2014

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open